Introduction of Yang Zijiang Pharmaceutical Industry

Yang Zijiang Pharmaceutical Group Co., Ltd. was established in 197 1, and is striding towards a "world-class enterprise". It is a national large-scale pharmaceutical enterprise group integrating Industry-University-Research, science, industry and trade, and the construction unit of the State Key Laboratory of New Technologies for Pharmaceutical Preparations.

Headquartered in Taizhou City, Jiangsu Province, a famous city in the Yangtze River Delta, the Group has more than 65,438+00,000 employees, with total assets of more than 654,38+000 billion yuan and a total area of more than 2 million square meters. Its comprehensive economic benefits rank first among the top 100 pharmaceutical industries in China, among the top 500 enterprise groups in China and the top 500 taxpayers in China, forming a unique scale advantage.

On September 10, 2020, the list of the top 500 private enterprises in China in 2020 was released, and Yang Zijiang Pharmaceutical Group Co., Ltd. ranked 7 1, with an operating income of 90185.03 million yuan.

On April 5th, 20021year, Yang Zijiang Pharmaceutical Group Co., Ltd. was suspected of reaching and implementing a monopoly agreement. According to the provisions of Articles 46 and 49 of the Anti-Monopoly Law, the General Administration of Market Supervision made a decision on administrative punishment, ordered Yang Zijiang Pharmaceutical Group to stop its illegal behavior, and imposed a fine of 3% on its sales of 20 18 of 25.467 billion yuan, accounting for 7%.

Extended data:

Corporate honor:

On July 5th, 20 19, Yang Zijiang Pharmaceutical was selected as "Top 20 18 China Chemical Pharmaceutical Enterprises 100", ranking second in the Top 100 list.

In July 2020, Yang Zijiang Pharmaceutical Group Co., Ltd. was selected as "Top 20 19 Innovative Enterprises in Jiangsu 100 List".

In July 2020, the list of China's most valuable brands 100 in 2020 was released, and Yang Zijiang Pharmaceutical Group Co., Ltd. ranked 62nd. ?

On September 10, 2020, the list of the top 500 private enterprises in China in 2020 was released, and Yang Zijiang Pharmaceutical Group Co., Ltd. ranked 7 1, with an operating income of 90185.03 million yuan.

On September 10, 2020, Yang Zijiang Pharmaceutical Group Co., Ltd. ranked 38th in "Top 500 Private Manufacturing Enterprises in China in 2020".

Baidu encyclopedia-Yang Zijiang drugstore